Caxton Associates (New York)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-85,578	Closed	-$911K	–	511
2023 Q2	$911K	Buy	+85,578	New	+$911K	0.13%	163
2020 Q1	–	Sell	-55,944	Closed	-$745K	–	484
2019 Q4	$745K	Buy	+55,944	New	+$745K	0.1%	109